Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis
By promoting the cytotoxic function of CD8+ T cells, immune checkpoint inhibitor therapy, e.g. programmed cell death protein-1 (PD-1), effectively inhibits tumor growth in renal cell carcinoma. Yet, as many as 87% of cancer patients do not respond to immune checkpoint therapy. Importantly, cytotoxic...
Guardado en:
Autores principales: | Cynthia L. Bristow, Mary Ann B. Reeves, Ronald Winston |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bb0a240dc204ceeb8ef6deca7ee997a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
por: M. Yu. Pervakova, et al.
Publicado: (2016) -
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
por: Dunlea DM, et al.
Publicado: (2018) -
Elevating the expression level of biologically active recombinant human alpha 1-antitrypsin in Pichia pastoris
por: Arjmand,Sareh, et al.
Publicado: (2013) -
Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
por: Sangachini,Elham Dasi, et al.
Publicado: (2012) -
Evaluation of Alpha-1 antitrypsin level in the serum of children with idiopathic bronchiectasis
por: Maryam Babaei, et al.
Publicado: (2021)